Functional Autoantibodies in Myocardial Diseases

Area of Science:

• Cardiovascular Medicine
• Immunology
• Translational Science

Background:

• Myocardial autoimmune responses drive cardiac diseases with poor outcomes.
• Autoantibodies (AAbs) target self-antigens, causing tissue injury and biventricular remodeling.
• The understanding of AAbs' role in myocardial disease has evolved from uniformly harmful to nuanced intracellular pathway influence.

Purpose of the Study:

• To critically appraise the latest translational data on autoantibodies in myocardial disease.
• To provide a framework for developing new therapeutics for cardiomyopathies.
• To explore the paradigm shift in understanding autoantibodies' role in cardiac autoimmunity.

Main Methods:

• Review of contemporary translational data.
• Analysis of technological advances including large language models for epitope screening.
• High-throughput protein assays to uncover autoimmune cross-reactivity and signaling pathways.

Main Results:

• Autoantibodies (AAbs) have a complex, multifaceted role in myocardial diseases.
• Technological advancements have revealed intricate autoimmune cross-reactivity and downstream signaling.
• A nuanced view of AAbs influencing intracellular pathways is emerging.

Conclusions:

• The role of autoantibodies in myocardial disease is complex and context-dependent.
• New therapeutic strategies for cardiomyopathies can be developed based on a deeper understanding of AAbs.
• Further scientific endeavors are encouraged to explore these complex autoimmune mechanisms.